PLK1 and Familial prostate cancer: Bl2536, which is a small molecule inhibitor of the mitotic kinase polo-like kinase 1 (Plk1), was demonstrated to inhibit Plkl during mitotic progression and lead to mitotic catastrophe, resulting in necroptotic cell death in androgen-insensitive prostate cancer cells [115].